Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

Investigative Site, Taipei

Investigative Site, Westmead

Investigative Site, Albury

Investigative Site, Herston

Investigative Site, Goyang-si

Investigative Site, Seongam

Investigative Site, Seongnam-si

Investigative Site, Genova

Investigative Site, Horsham

Investigative Site, Milan

Investigative Site, Columbia

Investigative Site, Dijon

Investigative Site, Arlington

Investigative Site, Norfolk

Investigative Site, Roanoke

Investigative Site, Besançon

Investigative Site, Pavia

Investigative Site, Madrid

Investigative Site, Madrid

Investigative Site, Madrid

Investigative Site, Majadahonda

Investigative Site, Asheville

Investigative Site, Atlanta

Investigative Site, Pamplona

Investigative Site, West Palm Beach

Investigative Site, St. Petersburg

Investigative Site, Verona

Investigative Site, Taichung

Investigative Site, Columbus

Investigative Site, Valencia

Investigative Site, Meldola

Investigative Site, Zaragoza

Investigative Site, Milwaukee

Investigative Site, Burnsville

Investigative Site, Lille

Investigative Site, Wichita

Investigative Site, Puglia

Investigative Site, Tainan City

Investigative Site, Baton Rouge

Investigative SIte, Hot Springs

Investigative Site, Paris

Investigative Site, Dallas

Investigative Site, Tyler

Investigative Site, San Antonio

Investigative Site, Austin

Investigative Site, Denver

Investigative Site, Tucson

Investigative Site, Poitiers

Investigative Site, Las Vegas

Investigative Site, Los Angeles

Investigative Site, Fullerton

Investigative Site, Bakersfield

Investigative Site, Portland

Investigative Site, Eugene

Investigative Site, Kaohsiung City

Investigative Site, Florham Park

Investigative Site, Seoul

Investigative Site, Seoul

Investigative Site, Seoul

Investigative Site, Seoul

Investigative Site, Seoul

Investigative Site, Barcelona

Investigative Site, Barcelona

Investigative Site, Taoyuan District